As the long summer fades away, the golden autumn quietly arrives. In this season full of harvest, Fubaiao Biotechnology also welcomes an important moment. The groundbreaking ceremony of the new R&D/production center was successfully completed on August 10th, marking a new milestone for the company's development!

The new site of Fubaiao Biotechnology Company is located in the fifth phase of the Biopharmaceutical Industry Park (BioBAY), with a total area of over 3200 square meters. It will be constructed in accordance with BSL-2 biosafety laboratory requirements and GMP quality system standards. Intended to provide high-quality virus and viroid vector products for in vitro diagnostics (IVD), cellular gene therapy (CGT), and vaccine development enterprises.

Thanks to the long-term recognition of customers, the help of partners, the support of investors, and the hard work of employees, Fubaiao Biotechnology will continue to adhere to the value concept of "quality, innovation, collaboration, and win-win" in a new environment, further focus on the research and development of virus and virus like carrier products, help the development of the biopharmaceutical industry, and contribute its own strength to the development of human health.